Who Won It

Contract award · 16 Mar 2026

NP90726l Tildrakizumab (Ilumetri®)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded “Tildrakizumab (Ilumetri®)” to Almirall for £844k.

No competitionMedical equipment & pharmaceuticalsScotland

BuyerThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Value £844k
WinnerAlmirall

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · Body governed by public law
Supplier
Almirall
Value
£844,250
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Official notice
024266-2026 on Find a Tender
Timeline
  1. Contract date16 Mar 2026
  2. Published17 Mar 2026Published 1 day after the contract date

Description

Supply of Tildrakizumab (Ilumetri®) to NHS Scotland. The Authority has awarded this framework as a single supplier Framework per line to one (1) Framework Participant.

About the supplier

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
27 Mar 2026
Almirall £2.69m

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

All contracts

More won by Almirall

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview